SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
ETR:COP

CompuGroup Medical SE & Co. KGaA - COP Price Target & Analyst Ratings

€36.40
-0.24 (-0.66%)
(As of 10/6/2022 12:00 AM ET)
Add
Compare
Today's Range
€35.78
€37.32
50-Day Range
€34.26
€45.36
52-Week Range
€34.08
€77.85
Volume
57,809 shs
Average Volume
68,245 shs
Market Capitalization
$1.85 billion
P/E Ratio
26.96
Dividend Yield
1.36%
Price Target
€64.79

CompuGroup Medical SE & Co. KGaA Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

€64.79
High Prediction€81.00
Average Prediction€64.79
Low Prediction€53.00
TypeCurrent
10/7/21 to 10/7/22
1 Month Ago
9/7/21 to 9/7/22
3 Months Ago
7/9/21 to 7/9/22
1 Year Ago
10/7/20 to 10/7/21
Consensus RatingN/AN/AN/A
Hold
Strong Buy N/A N/A N/A
0 Strong Buy rating(s)
Buy N/A N/A N/A
3 Buy rating(s)
Hold N/A N/A N/A
1 Hold rating(s)
Sell N/A N/A N/A
1 Sell rating(s)
Consensus Price Target€64.79€64.79€68.43€83.17
Get CompuGroup Medical SE & Co. KGaA Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for COP and its competitors with MarketBeat's FREE daily newsletter.


COP Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

COP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CompuGroup Medical SE & Co. KGaA Stock vs. The Competition

TypeCompuGroup Medical SE & Co. KGaAComputer and Technology Companies
Consensus Rating Score
0.00
2.58
Consensus RatingN/ABuy
News Sentiment RatingNegative News
Neutral News
MarketBeat
Community Rating
Outperform Votes
202
57.55%
Underperform Votes
149
42.45%
Avg. Outperform Votes
222
66.87%
Avg. Underperform Votes
110
33.13%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/2/2022Warburg Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Andreas Wolf
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€67.50+83.72%
8/31/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Martin Comtesse
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€60.00+58.73%
8/8/2022Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Charlotte Friedrichs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€65.00+55.95%
8/5/2022Baader Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Knut Woller
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€81.00+78.57%
8/5/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Nooshin Nejati
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€68.00+49.91%
6/20/2022Kepler Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set Target€53.00+38.53%
3/25/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Adam, Wood
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target€59.00+14.56%
11/5/2019HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetNeutral€59.00+4.61%
(Data available from 10/7/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












COP Price Target - Frequently Asked Questions

Do MarketBeat users like CompuGroup Medical SE & Co. KGaA more than its competitors?

MarketBeat users like CompuGroup Medical SE & Co. KGaA less than other Computer and Technology companies. 57.55% of MarketBeat users gave CompuGroup Medical SE & Co. KGaA an outperform vote while computer and technology companies recieve an average of 66.87% outperform votes by MarketBeat users.

Does CompuGroup Medical SE & Co. KGaA's stock price have much upside?

According to analysts, CompuGroup Medical SE & Co. KGaA's stock has a predicted upside of 52.85% based on their 12-month price targets.

What analysts cover CompuGroup Medical SE & Co. KGaA?

CompuGroup Medical SE & Co. KGaA has been rated by Baader Bank, Berenberg Bank, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, and Warburg Research in the past 90 days.


Stock Ratings Reports and Tools

This page (ETR:COP) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.